QQQ   424.34 (-0.70%)
AAPL   181.85 (+0.16%)
MSFT   399.70 (-0.77%)
META   467.76 (-0.74%)
GOOGL   142.05 (+0.66%)
AMZN   168.21 (+0.68%)
TSLA   193.43 (-0.17%)
NVDA   677.87 (-2.40%)
NIO   6.06 (+1.68%)
AMD   163.62 (-1.25%)
BABA   75.96 (+3.86%)
T   16.99 (+0.47%)
F   12.15 (-0.82%)
MU   80.39 (-0.40%)
CGC   3.36 (-5.08%)
GE   148.29 (-0.22%)
DIS   108.14 (-1.19%)
AMC   4.61 (-1.07%)
PFE   27.54 (-0.18%)
PYPL   57.96 (-1.14%)
XOM   104.30 (+1.51%)
QQQ   424.34 (-0.70%)
AAPL   181.85 (+0.16%)
MSFT   399.70 (-0.77%)
META   467.76 (-0.74%)
GOOGL   142.05 (+0.66%)
AMZN   168.21 (+0.68%)
TSLA   193.43 (-0.17%)
NVDA   677.87 (-2.40%)
NIO   6.06 (+1.68%)
AMD   163.62 (-1.25%)
BABA   75.96 (+3.86%)
T   16.99 (+0.47%)
F   12.15 (-0.82%)
MU   80.39 (-0.40%)
CGC   3.36 (-5.08%)
GE   148.29 (-0.22%)
DIS   108.14 (-1.19%)
AMC   4.61 (-1.07%)
PFE   27.54 (-0.18%)
PYPL   57.96 (-1.14%)
XOM   104.30 (+1.51%)
QQQ   424.34 (-0.70%)
AAPL   181.85 (+0.16%)
MSFT   399.70 (-0.77%)
META   467.76 (-0.74%)
GOOGL   142.05 (+0.66%)
AMZN   168.21 (+0.68%)
TSLA   193.43 (-0.17%)
NVDA   677.87 (-2.40%)
NIO   6.06 (+1.68%)
AMD   163.62 (-1.25%)
BABA   75.96 (+3.86%)
T   16.99 (+0.47%)
F   12.15 (-0.82%)
MU   80.39 (-0.40%)
CGC   3.36 (-5.08%)
GE   148.29 (-0.22%)
DIS   108.14 (-1.19%)
AMC   4.61 (-1.07%)
PFE   27.54 (-0.18%)
PYPL   57.96 (-1.14%)
XOM   104.30 (+1.51%)
QQQ   424.34 (-0.70%)
AAPL   181.85 (+0.16%)
MSFT   399.70 (-0.77%)
META   467.76 (-0.74%)
GOOGL   142.05 (+0.66%)
AMZN   168.21 (+0.68%)
TSLA   193.43 (-0.17%)
NVDA   677.87 (-2.40%)
NIO   6.06 (+1.68%)
AMD   163.62 (-1.25%)
BABA   75.96 (+3.86%)
T   16.99 (+0.47%)
F   12.15 (-0.82%)
MU   80.39 (-0.40%)
CGC   3.36 (-5.08%)
GE   148.29 (-0.22%)
DIS   108.14 (-1.19%)
AMC   4.61 (-1.07%)
PFE   27.54 (-0.18%)
PYPL   57.96 (-1.14%)
XOM   104.30 (+1.51%)
NASDAQ:CGC

Canopy Growth (CGC) Stock Price, News & Analysis

$3.36
-0.18 (-5.08%)
(As of 12:04 PM ET)
Today's Range
$3.33
$3.52
50-Day Range
$0.52
$5.66
52-Week Range
$3.30
$24.36
Volume
1.47 million shs
Average Volume
3.00 million shs
Market Capitalization
$306.13 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$4.87

Canopy Growth MarketRank™ Stock Analysis

Analyst Rating
Reduce
1.50 Rating Score
Upside/​Downside
44.8% Upside
$4.87 Price Target
Short Interest
Healthy
4.58% of Float Sold Short
Dividend Strength
N/A
Sustainability
-0.83
Upright™ Environmental Score
News Sentiment
0.29mentions of Canopy Growth in the last 14 days
Based on 8 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($4.58) to ($1.45) Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

3.15 out of 5 stars

Medical Sector

350th out of 932 stocks

Medicinals & Botanicals Industry

3rd out of 10 stocks


CGC stock logo

About Canopy Growth Stock (NASDAQ:CGC)

Canopy Growth Corporation is a renowned player in the cannabis industry. The company has its headquarters in Smiths Falls, Ontario, Canada, and is dedicated to enhancing lives through cannabis. Canopy Growth's mission revolves around delivering top-quality cannabis products and services that cater to the needs of both medical and recreational consumers.

Canopy Growth Corporation operates in the cultivation and distribution of various cannabis products, catering to both medical and recreational users. The company has established itself as a leading producer of cannabis products, offering a wide range of options to meet the diverse needs of its customers. From dried cannabis flowers to oils, soft gel capsules, and edibles, Canopy Growth provides a comprehensive selection of products to deliver consistent, high-quality experiences.

The company's target market encompasses a broad spectrum of individuals seeking the therapeutic benefits of cannabis, including those with medical conditions and those who consume cannabis for recreational purposes. Canopy Growth aims to destigmatize cannabis and promote its potential benefits across society by offering safe, reliable, innovative products.

Canopy Growth Corporation's key customers can be described as a mix of medical patients and adult consumers who value quality and reliability in their cannabis products. Medical patients rely on Canopy Growth for consistent and effective treatments, while recreational users appreciate the company's commitment to delivering a premium cannabis experience.

The company has achieved several significant milestones and garnered recognition for its contributions to the industry. Canopy Growth Corporation has been at the forefront of cannabis research and development, pioneering innovative cultivation techniques and product formulations. The company's dedication to quality and innovation has earned it numerous awards and accolades, further solidifying its position as a leader in the cannabis industry.

Canopy Growth Corporation boasts a competent management team that brings a wealth of expertise to the company. Under the leadership of Chief Executive Officer David Klein, the team combines diverse professional backgrounds to drive the company's operations effectively. 

The management team comprises individuals with extensive experience in various fields, including cannabis cultivation, pharmaceuticals, finance, and marketing. Each team member contributes unique expertise to guide the company's strategic direction, foster innovation and ensure operational excellence.

Canopy Growth Corporation's financial performance reflects the dynamic nature of the cannabis industry. The company has experienced fluctuations in revenue metrics as market conditions and regulations evolve. Analyzing long-term trends and broader industry benchmarks is crucial to comprehensively understand the company's financial position.

Over the past few years, Canopy Growth Corporation has demonstrated the ability to generate revenue driven by increasing consumer demand and expanding market opportunities. The company's revenue metrics reflect its market leadership and the widespread acceptance of its products.

Earnings metrics provide insights into Canopy Growth Corporation's profitability. As the cannabis industry undergoes rapid growth and regulatory changes, the company's earnings can fluctuate due to increased investments in research and development, marketing initiatives, and compliance with evolving regulations.

Profit margin metrics reflect the company's ability to generate sustainable returns. Canopy Growth Corporation has been focused on improving operational efficiency and optimizing its cost structure to enhance profitability. Evaluating profit margin metrics in the context of the company's ongoing investments and growth strategies is essential.

Debt levels are also important factors to consider in assessing the financial health of Canopy Growth Corporation. Responsible debt management ensures a balanced financial position, enabling the company to pursue growth opportunities while mitigating potential risks. By maintaining a prudent approach to debt, Canopy Growth Corporation aims to maintain financial stability and create long-term value for its shareholders.

Analyzing Canopy Growth Corporation's recent stock performance provides valuable insights into investor sentiment and market conditions. Various factors, including regulatory changes, industry news, macroeconomic trends, and investor perception of the cannabis sector, influence the company's share price.

Canopy Growth Corporation has experienced fluctuations in its stock price, reflecting the volatility and evolving nature of the cannabis industry. Monitoring the company's stock performance is vital to understand its market position and growth potential better. Investors can make informed decisions about their investments by analyzing the underlying factors contributing to the company's stock performance.

Canopy Growth Corporation operates within the broader cannabis industry, which has witnessed rapid expansion and evolving regulations. Several factors influence the company's competitive positioning, including brand reputation, product portfolio, distribution network, and research capabilities.

As a market leader, Canopy Growth Corporation enjoys advantages from early market entry and established partnerships. The company has built a strong brand that resonates with consumers seeking reliable, high-quality cannabis products. Canopy Growth's extensive distribution network ensures widespread market access and customer reach.

The cannabis industry is also characterized by intense competition and regulatory complexities. Canopy Growth Corporation faces competition from established players and emerging companies vying for market share. The evolving regulatory landscape presents challenges and uncertainties that require continuous adaptation and compliance efforts.

Despite these challenges, Canopy Growth Corporation remains well-positioned due to its brand recognition, established market presence, and commitment to research and development. The company's focus on innovation, strategic partnerships, and diversification efforts allows it to maintain a competitive edge in the industry.

Canopy Growth Corporation is poised to capitalize on numerous growth opportunities within the cannabis sector. As the industry expands and regulations evolve, the company can leverage its established brand, extensive distribution channels, and product innovation to capture market share.

One significant growth opportunity lies in the increasing acceptance of cannabis for medical purposes. Canopy Growth Corporation's strong presence in the medical cannabis market positions it to cater to the growing demand for therapeutic products. The company can tap into this market segment's potential by developing innovative treatment options and expanding its medical product portfolio.

Additionally, the ongoing global trend toward cannabis legalization opens up new markets and opportunities for Canopy Growth Corporation. The company's strategic partnerships, acquisitions, and geographic expansion efforts allow it to establish a presence in emerging markets and gain a competitive advantage.

Canopy Growth Corporation's focus on research and development presents opportunities for product innovation and differentiation. By investing in scientific research, the company can develop new cannabis-based formulations, delivery methods, and applications, further expanding its product offerings and addressing evolving consumer needs.

Despite its promising position in the cannabis industry, Canopy Growth Corporation faces risks and challenges that must be carefully managed. Domestic and international regulatory changes can significantly impact market dynamics and introduce uncertainties. The evolving nature of cannabis regulations, particularly in different jurisdictions, creates compliance, licensing, and product distribution challenges.

The intense competition within the cannabis industry is another significant challenge. As the market expands, more players enter the space, intensifying competition for market share. To maintain a competitive edge, Canopy Growth Corporation must continue differentiating itself through product quality, brand reputation, and innovative offerings.

The complex and evolving nature of the cannabis industry also poses risks related to market volatility and investor sentiment. The industry's growth potential attracts significant attention, but it is also subject to market fluctuations and changing investor sentiment, which can impact stock prices and overall market performance.

In response to these risks and challenges, Canopy Growth Corporation has implemented robust risk management strategies. The company maintains comprehensive compliance programs to ensure adherence to evolving regulations and standards. Additionally, Canopy Growth Corporation's focus on research and development, innovation, and strategic partnerships helps mitigate risks by fostering product differentiation, market expansion, and adaptability.

Furthermore, the company's commitment to sustainable and responsible business practices positions it favorably in an industry where environmental, social, and governance considerations are becoming increasingly important.

CGC Stock Price History

CGC Stock News Headlines

CANOPY GROWTH TO HOLD SPECIAL MEETING OF SHAREHOLDERS
CGC Feb 2024 5.000 call
An Unusual Way to Invest in Gold
Most financial experts recommend including gold in your investment mix to protect against rising prices and keep wealth secure. Investors are discovering a little-known way to benefit from gold, which offers the chance to gain from higher gold prices and mining successes while avoiding the costs of operating mines.
An Unusual Way to Invest in Gold
Most financial experts recommend including gold in your investment mix to protect against rising prices and keep wealth secure. Investors are discovering a little-known way to benefit from gold, which offers the chance to gain from higher gold prices and mining successes while avoiding the costs of operating mines.
Canopy Growth Earnings Preview
Canopy Growth to Raise $35M in Private Placement
See More Headlines
Receive CGC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Canopy Growth and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/05/2021
Today
2/21/2024
Fiscal Year End
3/31/2024
Next Earnings (Estimated)
6/27/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Medicinals & botanicals
Sub-Industry
N/A
Current Symbol
NASDAQ:CGC
Fax
N/A
Employees
1,621
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$4.87
High Stock Price Target
$6.60
Low Stock Price Target
$3.00
Potential Upside/Downside
+37.5%
Consensus Rating
Reduce
Rating Score (0-4)
1.50
Research Coverage
4 Analysts

Profitability

Net Income
$-2,479,930,000.00
Net Margins
-326.75%
Pretax Margin
-295.77%

Debt

Sales & Book Value

Annual Sales
$304.79 million
Book Value
$11.14 per share

Miscellaneous

Free Float
90,796,000
Market Cap
$322.53 million
Optionable
Optionable
Beta
1.27
7 Energy Stocks to Buy and Hold Forever Cover

Do you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.

Get This Free Report

Key Executives

  • Mr. David Eric Klein (Age 60)
    CEO & Director
    Comp: $1.76M
  • Ms. Judy Eunjoo Hong (Age 52)
    CFO & Principal Accounting Officer
    Comp: $558.39k
  • Dr. Christelle Gedeon L.L.B. (Age 42)
    Ph.D., Chief Legal Officer & Corporate Secretary
    Comp: $390.26k
  • Mr. Jonathan Di Tosto
    Chief Operations Officer
  • Mr. Thomas Shipley IV (Age 35)
    Senior VP of Quality Assurance & Chief Science Officer
  • Jason Green
    Head of Agriculture - Hemp Division
  • Mr. Chris Edwards
    Chief Insights Officer
  • Ms. Tara Rozalowsky
    Interim Chief Product Officer
  • Mr. Dave Paterson
    President of Canada
  • Mr. Jurgen Bickel
    MD and Co-Founder of STORZ & BICKEL GmbH














CGC Stock Analysis - Frequently Asked Questions

Should I buy or sell Canopy Growth stock right now?

4 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Canopy Growth in the last year. There are currently 2 sell ratings and 2 hold ratings for the stock. The consensus among Wall Street research analysts is that investors should "reduce" CGC shares.
View CGC analyst ratings
or view top-rated stocks.

What is Canopy Growth's stock price target for 2024?

4 Wall Street research analysts have issued twelve-month price objectives for Canopy Growth's stock. Their CGC share price targets range from $3.00 to $6.60. On average, they anticipate the company's stock price to reach $4.87 in the next year. This suggests a possible upside of 44.8% from the stock's current price.
View analysts price targets for CGC
or view top-rated stocks among Wall Street analysts.

How have CGC shares performed in 2024?

Canopy Growth's stock was trading at $5.11 at the beginning of the year. Since then, CGC stock has decreased by 34.2% and is now trading at $3.36.
View the best growth stocks for 2024 here
.

Are investors shorting Canopy Growth?

Canopy Growth saw a decline in short interest in the month of January. As of January 31st, there was short interest totaling 4,170,000 shares, a decline of 24.9% from the January 15th total of 5,550,000 shares. Based on an average daily volume of 2,960,000 shares, the days-to-cover ratio is currently 1.4 days. Approximately 4.6% of the company's shares are short sold.
View Canopy Growth's Short Interest
.

When is Canopy Growth's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, June 27th 2024.
View our CGC earnings forecast
.

How were Canopy Growth's earnings last quarter?

Canopy Growth Co. (NASDAQ:CGC) announced its quarterly earnings data on Friday, November, 5th. The company reported ($0.20) earnings per share (EPS) for the quarter, topping the consensus estimate of ($1.60) by $1.40. The firm had revenue of $145.70 million for the quarter, compared to analyst estimates of $145.63 million. Canopy Growth had a negative net margin of 326.75% and a negative trailing twelve-month return on equity of 73.48%. The firm's revenue was down 3.4% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $1.60 earnings per share.

When did Canopy Growth's stock split?

Canopy Growth's stock reverse split before market open on Wednesday, December 20th 2023. The 1-10 reverse split was announced on Wednesday, December 13th 2023. The number of shares owned by shareholders was adjusted after the market closes on Tuesday, December 19th 2023. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

Who are Canopy Growth's major shareholders?

Canopy Growth's stock is owned by many different retail and institutional investors. Top institutional investors include Simplex Trading LLC (0.00%), Mirae Asset Global Investments Co. Ltd. (0.26%), Verition Fund Management LLC (0.00%), AXS Investments LLC (0.11%), Citadel Advisors LLC (0.00%) and Goldman Sachs Group Inc. (0.06%). Insiders that own company stock include David Angelo Lazzarato, David Eric Klein, Judy Eun Joo Hong, Theresa Yanofsky and Thomas Carlton Stewart.
View institutional ownership trends
.

How do I buy shares of Canopy Growth?

Shares of CGC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:CGC) was last updated on 2/21/2024 by MarketBeat.com Staff